The original Remdesivir trial by the drug company was a high quality RCT (randomized control trial) - except that they stopped it early once they saw a statistically significant positive effect (even though the effect was somewhat underwhelming: just fewer days of recovery). To me this moving of the goal posts invalidates the quality of the RCT. This study from an independent body without a moving of the goal posts is a more trustworthy result.
With that being said, anti-virals often only work well when given very early (sometimes even as a preventative) and right now from looking at this study it doesn't seem like this was done. So this study may only be confirming what we already know about how anti-virals should be used (at a very early stage) but it will hopefully have the good effect of stopping improper usage.
With that being said, anti-virals often only work well when given very early (sometimes even as a preventative) and right now from looking at this study it doesn't seem like this was done. So this study may only be confirming what we already know about how anti-virals should be used (at a very early stage) but it will hopefully have the good effect of stopping improper usage.